PhD, Cancer and Cell Biology, University of Cincinnati, 2009
BS, Molecular and Cellular Biology, Ohio University, 2004
Sara Meyer, PhD
Associate Professor
Contact Information
Associate Professor
Education
Most Recent Peer-Reviewed Publications
- miR-196b-Oct1/2 axis regulates DNMT3A-mutant AML pathogenesis: ACUTE MYELOID LEUKEMIA
- In vivo models of subclonal oncogenesis and dependency in hematopoietic malignancy
- FLT3 tyrosine kinase inhibition modulates PRC2 and promotes differentiation in acute myeloid leukemia
- Context is key for FLT3-ITD
- miR-196b-TLR7/8 Signaling Axis Regulates Innate Immune Signaling and Myeloid Maturation in DNMT3A-Mutant AML
Research Interests
The Meyer Laboratory uses quantitative and computational biologic and genomics approaches and mouse models to define the underlying molecular and genetic mechanisms contributing to four major research themes:
- development, progression, pathogenic features of myeloid malignancies
- innate immune signaling in AML
- mutational and transcriptional heterogeneity of myeloid malignancies
- identification of new targets, combination therapies, and/or biomarkers of AML progression, and therapy response